Skip to content
10-Q

Quarterly Report

bluebird bio, Inc.

0001293971-24-000079

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 12, 2024 194.44M sh
Shares Diluted Q3 2024 · Sep 30, 2024 193.89M sh
Shares Diluted Q3 2024 · Sep 30, 2024 193.59M sh
Shares Diluted Q3 2024 · Sep 30, 2023 109.1M sh
Shares Diluted Q3 2024 · Sep 30, 2023 106.92M sh
Capex Q3 2024 · Sep 30, 2024 $2.11M
Capex Q3 2024 · Sep 30, 2023 $2.98M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$209.86M
Operating Cash Flow restated Q3 2024 · Sep 30, 2023 −$180.91M
Short Term Debt Q3 2024 · Sep 30, 2024 $70.6M
Short Term Debt Q3 2024 · Dec 31, 2023 $0
Cash And Equivalents Q3 2024 · Sep 30, 2024 $70.65M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $221.76M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $165.35M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$5.79M
Stockholders Equity Q3 2024 · Jun 30, 2024 $52.98M
Stockholders Equity Q3 2024 · Mar 31, 2024 $131.05M
Stockholders Equity Q3 2024 · Dec 31, 2023 $194.54M
Stockholders Equity restated Q3 2024 · Sep 30, 2023 $152.83M
Stockholders Equity restated Q3 2024 · Jun 30, 2023 $234.82M
Stockholders Equity restated Q3 2024 · Mar 31, 2023 $290.42M
Stockholders Equity restated Q3 2024 · Dec 31, 2022 $134.33M
Current Liabilities Q3 2024 · Sep 30, 2024 $296.03M
Current Liabilities Q3 2024 · Dec 31, 2023 $200.11M
Total Liabilities Q3 2024 · Sep 30, 2024 $470.84M
Total Liabilities Q3 2024 · Dec 31, 2023 $424.62M
Current Assets Q3 2024 · Sep 30, 2024 $150.81M
Current Assets Q3 2024 · Dec 31, 2023 $281.69M
Total Assets Q3 2024 · Sep 30, 2024 $465.06M
Total Assets Q3 2024 · Dec 31, 2023 $619.16M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.31
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.10
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$0.80
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$1.23
Eps Basic Q3 2024 · Sep 30, 2024 −$0.31
Eps Basic Q3 2024 · Sep 30, 2024 −$1.10
Eps Basic restated Q3 2024 · Sep 30, 2023 −$0.80
Eps Basic restated Q3 2024 · Sep 30, 2023 −$1.23
Sga Expense Q3 2024 · Sep 30, 2024 $39.77M
Sga Expense Q3 2024 · Sep 30, 2024 $136.48M
Sga Expense restated Q3 2024 · Sep 30, 2023 $40.77M
Sga Expense restated Q3 2024 · Sep 30, 2023 $118.7M
Rd Expense Q3 2024 · Sep 30, 2024 $23.17M
Rd Expense Q3 2024 · Sep 30, 2024 $73.41M
Rd Expense restated Q3 2024 · Sep 30, 2023 $58.5M
Rd Expense restated Q3 2024 · Sep 30, 2023 $131.54M
Net Income Q3 2024 · Sep 30, 2024 −$60.81M
Net Income Q3 2024 · Sep 30, 2024 −$212M
Net Income Q3 2024 · Jun 30, 2024 −$81.39M
Net Income Q3 2024 · Mar 31, 2024 −$69.8M
Net Income restated Q3 2024 · Sep 30, 2023 −$87.23M
Net Income restated Q3 2024 · Sep 30, 2023 −$131.09M
Net Income restated Q3 2024 · Jun 30, 2023 −$62.79M
Net Income restated Q3 2024 · Mar 31, 2023 $18.93M
Operating Income Q3 2024 · Sep 30, 2024 −$66.92M
Operating Income Q3 2024 · Sep 30, 2024 −$234M
Operating Income restated Q3 2024 · Sep 30, 2023 −$96.01M
Operating Income restated Q3 2024 · Sep 30, 2023 −$156.98M
Gross Profit Q3 2024 · Sep 30, 2024 −$1.17M
Gross Profit Q3 2024 · Sep 30, 2024 −$21.31M
Gross Profit restated Q3 2024 · Sep 30, 2023 $3.27M
Gross Profit restated Q3 2024 · Sep 30, 2023 $328K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $11.78M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $66.59M
Cost Of Revenue restated Q3 2024 · Sep 30, 2023 $9.13M
Cost Of Revenue restated Q3 2024 · Sep 30, 2023 $21.34M
Revenue Q3 2024 · Sep 30, 2024 $10.61M
Revenue Q3 2024 · Sep 30, 2024 $45.27M
Revenue Q3 2024 · Sep 30, 2023 $12.28M
Revenue Q3 2024 · Sep 30, 2023 $21.41M